BASAGLAR (Eli Lilly and Company)
Welcome to the PulseAid listing for the BASAGLAR drug offered from Eli Lilly and Company. This Insulin [Chemical/Ingredient],Insulin Analog [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Eli Lilly and Company |
| NON-PROPRIETARY NAME: | Insulin glargine |
| SUBSTANCE NAME: | INSULIN GLARGINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-12-16 |
| END MARKETING DATE: | 0000-00-00 |
BASAGLAR HUMAN PRESCRIPTION DRUG Details:
| Item Description | BASAGLAR from Eli Lilly and Company |
| LABELER NAME: | Eli Lilly and Company |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100([iU]/mL) |
| START MARKETING DATE: | 2015-12-16 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0002-7715_f28edb9a-75bd-4005-8c65-eefc64770124 |
| PRODUCT NDC: | 0002-7715 |
| APPLICATION NUMBER: | NDA205692 |
Other INSULIN GLARGINE Pharmaceutical Manufacturers / Labelers:
